Fidelity Investments’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,011,617
| Closed | -$96.1M | – | 5799 |
|
|
2024
Q4 | $96.1M | Sell |
10,011,617
-4,558,461
| -31% | -$23.8M | 0.01% | 1138 |
|
|
2024
Q3 | $41.7M | Buy |
14,570,078
+26,431
| +0.2% | +$81.8K | ﹤0.01% | 1448 |
|
|
2024
Q2 | $42.5M | Buy |
14,543,647
+70,278
| +0.5% | +$192K | ﹤0.01% | 1371 |
|
|
2024
Q1 | $46.2M | Buy |
14,473,369
+129,704
| +0.9% | +$432K | ﹤0.01% | 1355 |
|
|
2023
Q4 | $48.2M | Buy |
14,343,665
+1,306,236
| +10% | +$3.37M | ﹤0.01% | 1307 |
|
|
2023
Q3 | $31M | Buy |
13,037,429
+21,098
| +0.2% | +$44.2K | ﹤0.01% | 1430 |
|
|
2023
Q2 | $22.9M | Buy |
13,016,331
+37,251
| +0.3% | +$95.2K | ﹤0.01% | 1589 |
|
|
2023
Q1 | $40M | Buy |
12,979,080
+86,673
| +0.7% | +$519K | ﹤0.01% | 1341 |
|
|
2022
Q4 | $68.3M | Buy |
12,892,407
+343,355
| +3% | +$1.57M | 0.01% | 1120 |
|
|
2022
Q3 | $44.3M | Buy |
12,549,052
+3,143,344
| +33% | +$10.4M | ﹤0.01% | 1291 |
|
|
2022
Q2 | $24.3M | Buy |
9,405,708
+23,554
| +0.3% | +$65.5K | ﹤0.01% | 1575 |
|
|
2022
Q1 | $42M | Buy |
9,382,154
+6,213
| +0.1% | +$28K | ﹤0.01% | 1471 |
|
|
2021
Q4 | $63.9M | Buy |
9,375,941
+25,152
| +0.3% | +$171K | ﹤0.01% | 1319 |
|
|
2021
Q3 | $68.2M | Buy |
9,350,789
+27,583
| +0.3% | +$237K | 0.01% | 1281 |
|
|
2021
Q2 | $93.4M | Buy |
9,323,206
+6,981
| +0.1% | +$62.5K | 0.01% | 1146 |
|
|
2021
Q1 | $89M | Buy |
9,316,225
+43,224
| +0.5% | +$424K | 0.01% | 1119 |
|
|
2020
Q4 | $101M | Buy |
9,273,001
+75
| +0% | +$791 | 0.01% | 1025 |
|
|
2020
Q3 | $76.9M | Buy |
+9,272,926
| New | +$106M | 0.01% | 1039 |
|
Other funds holding PSTX
Fidelity Investments's PSTX Position: Q1 2025 in Review
Fidelity Investments sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 10,011,617 shares — an estimated $96.1M sold.
Fidelity Investments first reported a position in PSTX in Q3 2020 and held it in 18 quarters. The position peaked at $101M in Q4 2020. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.
- Fidelity Investments reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Fidelity Investments sold 10,011,617 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $96.1M.
- Fidelity Investments first reported a position in Poseida Therapeutics, Inc. Common Stock in Q3 2020 and held it in 18 quarters.
- Fidelity Investments's Poseida Therapeutics, Inc. Common Stock position peaked at $101M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.
Based on Fidelity Investments's 13F filing for Q1 2025, filed 12 May 2025.